Celldex Therapeutics Inc. (CLDX)
NASDAQ: CLDX
· Real-Time Price · USD
24.95
-0.04 (-0.16%)
At close: Aug 14, 2025, 3:59 PM
25.00
0.20%
Pre-market: Aug 15, 2025, 06:36 AM EDT
Celldex Therapeutics Fail-to-Deliver
Total FTD Shares
139
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-99.5%
Negative Trend
FTD Chart
As of Jul 10, 2025,
Celldex Therapeutics Inc. has
139
shares failed to deliver, representing 0.01%
of the average daily volume of
1,083,183
shares. Over the past year, the monthly average FTD is
2,856
shares, with the current level 95% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 10, 2025 | 22.68 | 139 | -93.04% |
Jun 24, 2025 | 21.65 | 2K | +5447.22% |
May 28, 2025 | 18.66 | 36 | -96.26% |
Apr 30, 2025 | 20.83 | 962 | -90.40% |
Mar 31, 2025 | 18.15 | 10.02K | +5143.98% |
Feb 27, 2025 | 20.31 | 191 | -98.12% |
Jan 22, 2025 | 24.24 | 10.17K | +92.29% |
Dec 30, 2024 | 25.12 | 5.29K | +695.34% |
Nov 27, 2024 | 27.89 | 665 | -88.07% |
Oct 29, 2024 | 26.86 | 5.58K | +729.61% |
Sep 30, 2024 | 33.99 | 672 | -87.77% |
Aug 30, 2024 | 41.33 | 5.5K | +6.64% |
Jul 29, 2024 | 41.99 | 5.15K | +515300.00% |
Jun 17, 2024 | 34.91 | 1 | -99.45% |
May 31, 2024 | 33.3 | 183 | +18200.00% |
Apr 23, 2024 | 37.77 | 1 | -99.87% |
Mar 25, 2024 | 41.44 | 759 | -25.07% |
Feb 14, 2024 | 36.26 | 1.01K | +75.87% |
Jan 04, 2024 | 39.11 | 576 | -37.59% |
Dec 29, 2023 | 39.66 | 923 | -96.48% |
Nov 10, 2023 | 26.94 | 26.19K | +1287.24% |
Sep 22, 2023 | 25.45 | 1.89K | +1908.51% |
Aug 14, 2023 | 31.07 | 94 | -56.48% |
Jul 28, 2023 | 34.7 | 216 | +881.82% |
Jun 30, 2023 | 33.93 | 22 | -66.67% |
May 26, 2023 | 30.57 | 66 | +100.00% |
Apr 25, 2023 | 33.98 | 33 | -95.97% |
Mar 24, 2023 | 36.56 | 818 | +2821.43% |
Feb 09, 2023 | 43.32 | 28 | -95.92% |
Jan 27, 2023 | 46.25 | 687 | n/a |